Cyclical Mechanics vs. Static Vacuum: The Next Battleground in Endovascular Thrombectomy
Dr. Dereck Mush, MD, MBA
Insera Therapeutics
Device company behind the CLEAR Aspiration System for peripheral clot removal.
Insera Therapeutics is known for device company behind the CLEAR Aspiration System for peripheral clot removal. It is based in Dallas-Fort Worth, Texas, USA, is at the Private stage, and sits in our Medical Devices category.
What they do
Insera Therapeutics makes the CLEAR Aspiration System, FDA 510(k) cleared on June 24, 2026 (K253404) for removing fresh, soft emboli and thrombi from peripheral arteries and veins. The clearance was announced September 28, 2026.
The record
- Vertical
- Medical Devices
- Sub-segment
- Peripheral thrombectomy
- Product type
- Medical device
- Stage
- Private
- Headquarters
- Dallas-Fort Worth, Texas, USA
- Region
- North America
- Founded
- Not disclosed
- Total funding
- Undisclosed
Also in Medical Devices
More in Medical Devices: Medical Devices startups/HealthTech startup database
Related on The Signal
Dr. Dereck Mush, MD, MBA
The Digital Therapeutics Evidence Gap: What FDA Authorization Actually Required
Dr. Dereck Mush, MD, MBA
The MCT8 Treatment Boundary: What Emcitate's Approval Changes and What It Leaves Open
Dr. Dereck Mush, MD, MBA
Medicare finally pays for prescription digital therapeutics, and the test begins
Dr. Dereck Mush, MD, MBA